IDO1 and cyst: Since genetic loss of Ido1 or 1-MT treatment in our PKD model not only reduced kidney kynurenine/kynurenic acid levels, but also slowed cyst growth, we hypothesized inhibition of immunosuppressive pathways to be an underlying mechanism.